Skip to content

Scleroderma ARFI Imaging of the Skin

Acoustic Radiation Force Impulse/Shear Wave Velocity Imaging of the Skin in Scleroderma and Other Rheumatologic Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02006420
Acronym
ARFI
Enrollment
45
Registered
2013-12-10
Start date
2013-12-31
Completion date
2015-12-31
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma

Brief summary

Scleroderma and other rheumatologic conditions can affect the skin. Scleroderma in particular involves skin thickening and hardening. Currently, looking at the degree that the skin is affected by scleroderma is measured based on a combination of a physical exam and a skin biopsy. The researchers propose to measure skin hardness using ultrasound imaging of elasticity. They will use a technique using acoustic radiation force impulse/shear wave velocity imaging , known as ARFI/SVI). The investigators hypothesize that ARFI/SVI may be able to distinguish between normal skin and skin affected by scleroderma.. This tool may also help to quantify the amount of fibrosis in the skin. This type of radiologic biomarker could be used to help confirm the diagnosis of scleroderma.

Detailed description

Scleroderma as well as numerous other rheumatologic conditions can affect the skin. Scleroderma in particular causes skin thickening and hardening. Currently, evaluation of degree to which skin is affected by scleroderma is measured by a combination of a physical exam and skin biopsy results. The investigators propose to measure skin hardness using ultrasound elasticity imaging, in the form of acoustic radiation force impulse/shear wave velocity imaging (ARFI/SVI). The investigators hypothesize that ARFI/SVI may be able to distinguish normal skin from skin affected by scleroderma (and other rheumatologic conditions). And, this ultrasound technique might measure the amount of fibrosis in the dermis (skin). Such a radiologic biomarker could be used to help confirm the diagnosis of scleroderma. In addition, it may be usable for following patients over time and measuring their response to therapy and progression of disease.

Interventions

DEVICEARFI-SVI Ultrasound

Ultrasound imaging of arm and leg lasting approximately 5-10 minutes. Participants will also undergo durometer scoring on the forearm and thigh as part of the study. This lasts approximately 5-10 minutes.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. 18 years of age or older 2. Rheumatologic disease of the skin including: Limited Scleroderma, Diffuse Scleroderma, or Eosinophilic Fascitis (Schulman's Syndrome)

Exclusion criteria

1\. None

Design outcomes

Primary

MeasureTime frameDescription
Mean Skin StiffnessCross-sectional study, 1 visit, <1 hrSkin stiffness was measured from the forearm and thigh of patients with scleroderma using ultrasound shear wave velocity imaging. Shear wave velocity is measured in meters per second (m/s).

Secondary

MeasureTime frameDescription
Linear Relationship Between Ultrasound Skin Stiffness and DurometerCross-sectional study, 1 visit, <1 hrPearson correlation assesses the linear relationship between Ultrasound skin stiffness measurements and Durometer scoring of skin stiffness. Data was combined for scleroderma and control subjects to assess the relationship and association across a broad range of skin conditions.
Mean Landmark ScoresCross-sectional study, 1 visit, <1 hrMean Landmark scores are on a scale of 0 to 3, 0 = normal and 3 =marked skin hardening.
Mean Skin Stiffness as Measured by Durometer ScoringCross-sectional study, 1 visit, <1 hrDurometer scoring of skin stiffness in two groups of patients (controls and scleroderma). Durometer measurements are expressed in standardized international durometer units ranging from 0 to 100 where 100 is harder (worse outcome) The Rex Gauge model DD-3 was used. For further reference see Arthritis and Rheumatism (Arthritis Care & Research) Vol. 55. No. 4, August 15, 2006, pp. 603-609. DOI 10.1002/art.22093.
MRSS Scores for Scleroderma Participants.Cross-sectional study, 1 visit, <1 hrMRSS scores exist on a scale from 0 to 51 based on scores of 0 to 3 measured in 17 locations on the body, where 0 represents overall healthy skin and 51 would be the worst outcome in all 17 locations. MRSS measures are not taken on healthy participants.
Linear Relationship Between Ultrasound Skin Stiffness and MRSSCross-sectional study, 1 visit, <1 hrPearson correlation assesses the linear relationships between ultrasound skin stiffness and subjective skin scoring (MRSS) of skin stiffness. MRSS is the Modified Rodnan Score. Skin thickness is measured by clinical palpation using a 0-3 scale. 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold. Because MRSS measurements were not taken for healthy participants, no correlations are provided for them. Therefore, the correlations are based on a skin stiffness and skin scoring solely for scleroderma participants.
Linear Relationship Between Ultrasound Skin Stiffness and LandmarkCross-sectional study, 1 visit, <1 hrPearson correlation assesses the linear relationship between ultrasound skin stiffness and subjective skin scoring (Landmark) of skin stiffness in all patients (controls plus scleroderma). Data was combined for scleroderma and control subjects to assess the relationship and association across a broad range of skin conditions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Scleroderma
Ultrasound imaging of forearm and thigh, lasting approximately 5-10 minutes. ARFI-SVI Ultrasound: Ultrasound imaging of arm and leg lasting approximately 5-10 minutes. Participants will also undergo durometer scoring on the forearm and thigh as part of the study. This lasts approximately 5-10 minutes.
24
Control
Ultrasound imaging of forearm and thigh, lasting approximately 5-10 minutes. ARFI-SVI Ultrasound: Ultrasound imaging of arm and leg lasting approximately 5-10 minutes. Participants will also undergo durometer scoring on the forearm and thigh as part of the study. This lasts approximately 5-10 minutes.
21
Total45

Baseline characteristics

CharacteristicSclerodermaControlTotal
Age, Continuous48.7 years
STANDARD_DEVIATION 14.6
47.7 years
STANDARD_DEVIATION 14.68
48.2 years
STANDARD_DEVIATION 14.65
Sex: Female, Male
Female
17 Participants16 Participants33 Participants
Sex: Female, Male
Male
7 Participants5 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 21
other
Total, other adverse events
0 / 240 / 21
serious
Total, serious adverse events
0 / 240 / 21

Outcome results

Primary

Mean Skin Stiffness

Skin stiffness was measured from the forearm and thigh of patients with scleroderma using ultrasound shear wave velocity imaging. Shear wave velocity is measured in meters per second (m/s).

Time frame: Cross-sectional study, 1 visit, <1 hr

ArmMeasureGroupValue (MEAN)Dispersion
SclerodermaMean Skin StiffnessForearm2.68 meters per secondStandard Deviation 0.82
SclerodermaMean Skin StiffnessThigh2.23 meters per secondStandard Deviation 0.48
ControlMean Skin StiffnessForearm2.07 meters per secondStandard Deviation 0.25
ControlMean Skin StiffnessThigh2.27 meters per secondStandard Deviation 0.36
Comparison: This is the p value for the mean skin thickness of the forearm.p-value: 0.005t-test, 2 sided
Comparison: This is the p value for the mean skin stiffness of the thighp-value: 0.71t-test, 2 sided
Secondary

Linear Relationship Between Ultrasound Skin Stiffness and Durometer

Pearson correlation assesses the linear relationship between Ultrasound skin stiffness measurements and Durometer scoring of skin stiffness. Data was combined for scleroderma and control subjects to assess the relationship and association across a broad range of skin conditions.

Time frame: Cross-sectional study, 1 visit, <1 hr

ArmMeasureGroupValue (NUMBER)
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and DurometerForearm0.45 Correlation coefficient
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and DurometerThigh0.40 Correlation coefficient
Comparison: This is the p value for the forearm.p-value: 0.002Pearson correlation
Comparison: This is the p value for the thighp-value: 0.007Pearson correlation
Secondary

Linear Relationship Between Ultrasound Skin Stiffness and Landmark

Pearson correlation assesses the linear relationship between ultrasound skin stiffness and subjective skin scoring (Landmark) of skin stiffness in all patients (controls plus scleroderma). Data was combined for scleroderma and control subjects to assess the relationship and association across a broad range of skin conditions.

Time frame: Cross-sectional study, 1 visit, <1 hr

ArmMeasureGroupValue (NUMBER)
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and LandmarkForearm.65 correlation coefficient
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and LandmarkThigh.55 correlation coefficient
Comparison: This is the p-value for the forearmp-value: <0.0001Pearson correlation
Comparison: This is the p-value for the thighp-value: <0.0001Pearson correlation
Secondary

Linear Relationship Between Ultrasound Skin Stiffness and MRSS

Pearson correlation assesses the linear relationships between ultrasound skin stiffness and subjective skin scoring (MRSS) of skin stiffness. MRSS is the Modified Rodnan Score. Skin thickness is measured by clinical palpation using a 0-3 scale. 0 = normal skin; 1 = mild thickness; 2 = moderate thickness; 3 = severe thickness with inability to pinch the skin into a fold. Because MRSS measurements were not taken for healthy participants, no correlations are provided for them. Therefore, the correlations are based on a skin stiffness and skin scoring solely for scleroderma participants.

Time frame: Cross-sectional study, 1 visit, <1 hr

Population: Data for 2 of 24 participants is not available.

ArmMeasureGroupValue (NUMBER)
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and MRSSForearm0.53 correlation coefficient
SclerodermaLinear Relationship Between Ultrasound Skin Stiffness and MRSSThigh0.36 correlation coefficient
Comparison: This is the p-value for the forearmp-value: 0.01Pearson correlation
Comparison: This is the p-value for the thighp-value: 0.1Pearson correlation
Secondary

Mean Landmark Scores

Mean Landmark scores are on a scale of 0 to 3, 0 = normal and 3 =marked skin hardening.

Time frame: Cross-sectional study, 1 visit, <1 hr

ArmMeasureGroupValue (MEAN)
SclerodermaMean Landmark ScoresForearm0.6667 units on a scale
SclerodermaMean Landmark ScoresThigh0.58333 units on a scale
ControlMean Landmark ScoresForearm0 units on a scale
ControlMean Landmark ScoresThigh0 units on a scale
Secondary

Mean Skin Stiffness as Measured by Durometer Scoring

Durometer scoring of skin stiffness in two groups of patients (controls and scleroderma). Durometer measurements are expressed in standardized international durometer units ranging from 0 to 100 where 100 is harder (worse outcome) The Rex Gauge model DD-3 was used. For further reference see Arthritis and Rheumatism (Arthritis Care & Research) Vol. 55. No. 4, August 15, 2006, pp. 603-609. DOI 10.1002/art.22093.

Time frame: Cross-sectional study, 1 visit, <1 hr

ArmMeasureGroupValue (MEAN)Dispersion
SclerodermaMean Skin Stiffness as Measured by Durometer ScoringForearm30.5 units on a scaleStandard Deviation 9.4
SclerodermaMean Skin Stiffness as Measured by Durometer ScoringThigh30.1 units on a scaleStandard Deviation 8.5
ControlMean Skin Stiffness as Measured by Durometer ScoringForearm19.1 units on a scaleStandard Deviation 2.8
ControlMean Skin Stiffness as Measured by Durometer ScoringThigh19.3 units on a scaleStandard Deviation 3.5
Comparison: This is the p-value for the forearmp-value: 0.002Pearson correlation
Comparison: This is the p-value for the thighp-value: 0.007Pearson correlation
Secondary

MRSS Scores for Scleroderma Participants.

MRSS scores exist on a scale from 0 to 51 based on scores of 0 to 3 measured in 17 locations on the body, where 0 represents overall healthy skin and 51 would be the worst outcome in all 17 locations. MRSS measures are not taken on healthy participants.

Time frame: Cross-sectional study, 1 visit, <1 hr

Population: Of 24 scleroderma participants, data was not available for 2.

ArmMeasureValue (MEAN)
SclerodermaMRSS Scores for Scleroderma Participants.11.27273 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026